2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with 6 beta-hydroxycortisol in 1 studies
Studies (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) | Trials (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) | Recent Studies (post-2010) (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) | Studies (6 beta-hydroxycortisol) | Trials (6 beta-hydroxycortisol) | Recent Studies (post-2010) (6 beta-hydroxycortisol) |
---|---|---|---|---|---|
135 | 6 | 50 | 286 | 65 | 51 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnaud, P; Boulton, DW; DeVane, CL | 1 |
1 trial(s) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and 6 beta-hydroxycortisol
Article | Year |
---|---|
A single dose of methadone inhibits cytochrome P-4503A activity in healthy volunteers as assessed by the urinary cortisol ratio.
Topics: Analysis of Variance; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Female; Humans; Hydrocortisone; Methadone; Narcotics; Oxidoreductases, N-Demethylating; Pyrrolidines | 2001 |